In Pain due to muscle spasm Mylax 350mg/350mg Tablet treats pain due to muscle spasm by relaxing stiff muscles. It also reduces swelling in the muscles. Altogether, it helps in easy movement and reduces discomfort. Mylax 350mg/350mg Tablet also helps reduce fever associated with muscular pain. Once you see some improvement, you can start doing therapy exercises (such as walking or breathing exercises) that will help you get your strength back more quickly. Talk to your doctor about how much exercise is good for you.
It is unsafe to consume alcohol with Mylax 350mg/350mg Tablet.
Mylax 350mg/350mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Mylax 350mg/350mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Mylax 350mg/350mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Mylax 350mg/350mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Mylax 350mg/350mg Tablet may be needed. Please consult your doctor.
Mylax 350mg/350mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Mylax 350mg/350mg Tablet may be needed. Please consult your doctor.
If you miss a dose of Mylax 350mg/350mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More